Study of Milnacipran for the Treatment of Fibromyalgia

Completed · Phase 3 · Has a placebo group

Conditions studied: Fibromyalgia

In brief

The purpose of this study was to demonstrate the efficacy and safety of milnacipran at a dosage of 100 mg/day in the treatment of the fibromyalgia syndrome or the pain associate with fibromyalgia.

Key facts

Study ID

NCT00314249

Run by

Forest Laboratories

People needed

1025

Starts

2006-04-01

Last updated by the study team

2010-01-20

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• diagnosis of fibromyalgia defined by 1990 American College of Rheumatology (ACR) Criteria

You may not qualify if…

• psychiatric illness,
• depression,
• suicidal risk,
• substance abuse,
• pulmonary dysfunction,
• renal impairment,
• active cardiac disease,
• liver disease,
• autoimmune disease,
• cancer,
• inflammatory bowel disease

Where it is running

• Forest Investigative Site — Tuscaloosa, Alabama, United States
• Forest Investigative Site — Fresno, California, United States
• Forest Investigative Site — Pismo Beach, California, United States
• Forest Investigative Site — Vista, California, United States
• Forest Investigative Site — St. Petersburg, Florida, United States
• Forest Investigative Site — St. Petersburg, Florida, United States
• Forest Investigative Site — Stuart, Florida, United States
• Forest Investigative Site — Atlanta, Georgia, United States
• Forest Investigative Site — Springfield, Massachusetts, United States
• Forest Investigative Site — Worcester, Massachusetts, United States
• Forest Investigative Site — Omaha, Nebraska, United States
• Forest Investigative Site — Haddon Heights, New Jersey, United States
• Forest Investigative Site — Johnson City, New York, United States
• Forest Investigative Site — Syracuse, New York, United States
• Forest Investigative Site — Greensboro, North Carolina, United States
• Forest Investigative Site — Cleveland, Ohio, United States
• Forest Investigative Site — Columbus, Ohio, United States
• Forest Investigative Site — Toledo, Ohio, United States
• Forest Investigative Site — Eugene, Oregon, United States
• Forest Investigative Site — Mechanicsburg, Pennsylvania, United States
• Forest Investigative Site — Anderson, South Carolina, United States
• Forest Investigative Site — Greer, South Carolina, United States
• Forest Investigative Site — Richardson, Texas, United States
• Forest Investigative Site — Virginia Beach, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.